都柏林首个受监管的药物注射站点尽管证明对公众健康有利,但在居民就证据和安全关切提出呼吁后仍面临停顿。 Dublin’s first supervised drug injection site faces pause after resident appeal over evidence and safety concerns, despite proven public health benefits.

在一名当地居民以不完整的证据、缺乏独立审查以及对安全和分区的担忧为由对该决定提出质疑后,都柏林在Merchant Quay的第一个受医疗监督的药物注射站的永久规划许可被暂停。 Permanent planning permission for Dublin’s first medically supervised drug injection site at Merchant’s Quay has been paused after a local resident challenged the decision, citing incomplete evidence, lack of independent review, and concerns over safety and zoning. 该设施自2024年12月以来运作,在超过10 700次访问中为近1 200人提供了服务,在减少过量剂量、紧急服务使用和公共药物使用方面受到赞扬。 The facility, operating since December 2024, has served nearly 1,200 people across over 10,700 visits and is credited with reducing overdoses, emergency service use, and public drug use. 上诉书向An Coimisiún Pleanála提出,质疑HSE的审查是否充分以及利益攸关方的意见。 The appeal, filed with An Coimisiún Pleanála, questions the adequacy of the HSE’s review and stakeholder input. 目前的临时授权在2026年6月到期。 The current temporary authorization expires in June 2026.